Hexarelin

Overview

Hexarelin is a synthetic growth hormone secretagogue peptide belonging to the hexapeptide class. It is studied in laboratory environments for its ability to stimulate the pituitary gland to release growth hormone by binding to the ghrelin receptor (GHS-R) in preclinical models such as laboratory rodents. Hexarelin is often researched alongside GHRH analogs to investigate synergistic effects on natural growth hormone pathways.

Benefits

Recent preclinical studies indicate that Hexarelin may help increase natural growth hormone secretion, promote protein synthesis, enhance muscle cell growth, and support tissue repair in test subjects. Additionally, Hexarelin has been explored for its potential cardioprotective effects in certain animal models, making it a versatile research compound.
Source: Chang L, et al. Hexarelin exerts cardioprotective and anti-fibrotic effects in rats with heart failure. Frontiers in Pharmacology, 2020. Link

Possible Side Effects

In laboratory studies, test subjects administered Hexarelin may exhibit mild side effects such as temporary injection site irritation, slight water retention, or increased appetite-like responses. Some studies have also noted mild fluctuations in blood glucose levels depending on the dosage and duration of administration.
Source: Chang L, et al., Front Pharmacol, 2020.

Dosage & Administration

Hexarelin is typically administered via subcutaneous injection following approved laboratory protocols. Typical research dosages range from 100 mcg to 200 mcg per injection, commonly administered once or twice daily depending on study goals, species, and desired endpoints. It may be combined with other growth hormone releasing peptides or GHRH analogs to study synergistic effects.
For laboratory research use only. Not for human consumption.

Summary

Hexarelin is a synthetic growth hormone secretagogue peptide developed exclusively for laboratory research exploring natural growth hormone release, muscle growth, and tissue repair in preclinical models. Studies suggest it may help increase growth hormone secretion and support cardioprotective effects, with mild side effects such as increased appetite or injection site irritation occasionally observed in test subjects. Hexarelin is administered via subcutaneous injection, with dosage and frequency adjusted according to the study’s goals and the test species.
Strictly for research purposes only. Not for human use.